RCA Telegram News California - News from San Francisco, California, the USA and the world, around the clock every day

Vodafone Ireland Goes Live with Amdocs Network Inventory to Drive Network Automation and Simplification
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results
Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

EXXUA -- with only a partial quarter of full sales force support -- contributed $2.4 million in net revenue supported by rapid monthly compounding script growth ratesTotal net revenue of $12.4 millionAdjusted EBITDA1 of $(2.8) million, which includes EXXUA™ (gepirone) extended-release tablets ("EXXUA") launch investments as the Company enters the over $22 billion United States prescription major depressive disorder ("MDD") market$26.7 million cash balance at March 31, 2026Company to host conference call and webcast today, May 13, 2026, at 4:30 p.m. Eastern time

May 13, 2026

RECENT NEWS

Amdocs Limited Reports Second Quarter Fiscal 2026 Results
Amdocs Limited Reports Second Quarter Fiscal 2026 Results

Revenue of $1.17 Billion, up 3.9% YoY as Reported and up 2.2% YoY in Constant Currency(1)Expects Fiscal 2026 Revenue Growth Outlook of 2.6%-4.6% YoY as ReportedReiterates Midpoint of Fiscal 2026 Revenue Growth Outlook in Constant Currency(1) while Tightening Expected Range to 2.0%-4.0% YoYAnnounces Retirement of Long-Serving CFO and Appointment of Internal CFO SuccessorSecond Quarter Fiscal 2026 Highlights(All comparisons are against same quarter of the prior year, unless otherwise stated)Revenue of $1,172 million, up 3.9% as reported and up 2.2% in constant currency(1); revenue was above the midpoint of the $1,150-$1,190 million guidance range and includes a positive impact from foreign currency movements of approximately $2 million relative to our guidance assumptionsRevenue of $754 million in North America, up 2.2%; record revenue of $192 million in Europe, up 6.2%; revenue of $226 million in Rest of World, up 8.0% Managed services revenue of $759 million, equivalent to approximately 65% of total revenue and up 1.6% GAAP diluted EPS of $1.28, above the midpoint of the guidance range of $1.22-$1.30Non-GAAP diluted EPS of $1.78, above the midpoint of the guidance range of $1.73-$1.79GAAP operating income of $183 million; GAAP operating margin of 15.6%, down 190 basis points compared to last year’s second quarter and 230 basis points sequentially, mainly due to costs related to leadership transition as well as benefit from changes in certain acquisitions related liabilities measured at fair value in the first fiscal quarterNon-GAAP operating income of $252 million; non-GAAP operating margin of 21.5%, up 20 basis points as compared to last year’s second fiscal quarter and down 10 basis points sequentially Free cash flow of $80 million, comprised of cash flow from operations of $102 million, including $17 million of restructuring payments, less $21 million in net capital expenditures(2); excluding restructuring payments, free cash flow was $97 million; reiterates full year fiscal 2026 free cash outlook of $710 million to $730 million, excluding restructuring paymentsRepurchased $138 million of ordinary shares during the second fiscal quarterTwelve-month backlog of $4.28 billion, up $30 million sequentially and up 2.6% Amdocs Limited (the “Company” or “Amdocs”) announced today that Tamar Rapaport-Dagim, Chief Financial Officer and Chief Operating Officer, has decided to retire from the Company following a distinguished career spanning over two decades. Tal Rozenfeld, currently General Manager Head of Finance, has been appointed Chief Financial Officer, effective June 1st, 2026. Tamar will continue to complete the transition process to help ensure a seamless handover of responsibilities.(1) Revenue on a constant currency basis assumes exchange rates in the current period were unchanged from the prior period(2)Please refer to the Selected Financial Metrics tables below (figures may not sum because of rounding)

May 13, 2026

MicroVision Announces First Quarter 2026 Results
MicroVision Announces First Quarter 2026 Results

REDMOND, WA / ACCESS Newswire / May 13, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its first quarter 2026 results.

May 13, 2026

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products -- Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to support skin renewal, in the middle of 2026 -- Raised $2.0 million in net proceeds from it's at-the-market ("ATM") financing facility -

May 13, 2026

RECENT NEWS

Sport Beach Announces Initial Programming Lineup for Cannes 2026 Alongside Key Brands and Athletes
Sport Beach Announces Initial Programming Lineup for Cannes 2026 Alongside Key Brands and Athletes

New athletes joining the programming include Ken Griffey Jr., Noah Lyles, CC Sabathia, Maria Sharapova, Jaxon Smith-Njigba, Tara Davis-Woodhall and Hunter Woodhall

May 13, 2026

RECENT NEWS

AI Search Engineers Introduces the AEO Differentiation Standard, the First Classification Framework Separating AI Certified Agencies From SEO Rebrands
AI Search Engineers Introduces the AEO Differentiation Standard, the First Classification Framework Separating AI Certified Agencies From SEO Rebrands

As hundreds of agencies rebrand traditional SEO services as AI search optimization, AI Search Engineers releases the first outcome-based standard for evaluating genuine AEO expertise, and becomes the only agency in the United States qualifying as Tier 1 AEO Verified

May 13, 2026